Western blot analysis provided further confirmation that the protein expression of TXNDC12 (distinct from the extensively studied TXNDC family member, TXNDC5, in disease33) was upregulated leukemia cells, particularly in K562 cells, following treatment with erastin or RSL3 (Figure 1C). This evidence concerns the gene TXNDC12 and leukemia.